Onvitrelin ucalontide

Modify Date: 2024-02-04 05:37:01

Onvitrelin ucalontide Structure
Onvitrelin ucalontide structure
Common Name Onvitrelin ucalontide
CAS Number 1174415-90-7 Molecular Weight 3316.94
Density N/A Boiling Point N/A
Molecular Formula C163H243N43O32 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Onvitrelin ucalontide


Onvitrelin ucalontide ([Phor18-LHRH (338613)]) is an analogue of luteinizing hormone releasing hormone (LHRH) with antineoplastic activity. Onvitrelin ucalontide is a peptide with sequences of KFAKFAKKFAKFAKKFAKQHWSYGLRPG. Onvitrelin ucalontide effectively inhibits breast cancer, ovarian cancer and prostate cancer xenografts in mouse model[1][2].

 Names

Name Onvitrelin ucalontide

 Onvitrelin ucalontide Biological Activity

Description Onvitrelin ucalontide ([Phor18-LHRH (338613)]) is an analogue of luteinizing hormone releasing hormone (LHRH) with antineoplastic activity. Onvitrelin ucalontide is a peptide with sequences of KFAKFAKKFAKFAKKFAKQHWSYGLRPG. Onvitrelin ucalontide effectively inhibits breast cancer, ovarian cancer and prostate cancer xenografts in mouse model[1][2].
Related Catalog
References

[1]. Leuschner Carola, et al. Lytic domain fusion constructs and methods of making and using same for treating cell proliferation disorders: World Intellectual Property Organization, WO2009094634. 2009-07-30.

[2]. WHO Drug Information-World Health Organization (WHO).

 Chemical & Physical Properties

Molecular Formula C163H243N43O32
Molecular Weight 3316.94
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.